<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): December 8, 2008</B>



<P style="font-size: 24pt" align="center"><B>CEREPLAST, INC.<BR>
</B><FONT
style="font-size: 10pt">(Exact name of registrant as specified in its charter)
</FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Nevada</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>333-126378</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>91-2154289</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>3411-3421 West El Segundo
Boulevard, Hawthorne, California</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>90250</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(310) 676-5000</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>Not Applicable</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>



<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="justify"><B>SECTION 1. REGISTRANT&#8217;S
BUSINESS AND OPERATIONS</B>

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD nowrap align="left" width="3%"><B>Item&nbsp;1.01</B></TD>
  <TD width="1%">&nbsp;</TD>
  <TD>
<DIV style="text-align: justify"><B>Entry Into a Material Definitive
Agreement</B></DIV>
</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt; text-indent: 4%" align="justify">On December&nbsp;8,
2008, Cereplast, Inc., a Nevada corporation (the &#8220;Company&#8221;) entered
into a Periodic Equity Investment Agreement (the &#8220;Agreement&#8221;) with
Cumorah Capital, Inc., a Nevada corporation (&#8220;Cumorah&#8221;). Under the
Agreement, Cumorah has agreed to invest up to $20,000,000 of capital into the
Company during the term of the Agreement at the rate of $250,000 per
investment, subject to the ongoing satisfaction of certain conditions specified
in the Agreement. The Agreement commences on December&nbsp;8, 2008 and
terminates on the earlier to occur of (i)&nbsp;the date the total maximum
investments of $20,000,000 is made under the Agreement,
(ii)&nbsp;December&nbsp;8, 2010, or (iii)&nbsp;the date the Agreement is
automatically terminated because of the occurrence of any of the events
described in Section&nbsp;2.4 of the Agreement.

<P style="font-size: 10pt; text-indent: 4%" align="justify">In response to
requests for equity investments by the Company from time to time during the
term of the Agreement, Cumorah may fulfill its funding obligation by purchasing
the Company&#8217;s common stock at a purchase price equal to 90% of the market
price, if the stock is covered by a Registration Statement filed pursuant to
Section&nbsp;5 of the Securities Act of 1933, as amended, or 60% of the market
price, if the stock is restricted and not registered.

<P style="font-size: 10pt; text-indent: 4%" align="justify">The Agreement
defines the market price as the lowest closing bid price of the Company&#8217;s
common stock on the OTC Bulletin Board during the five consecutive trading days
immediately preceding the date that the Company delivers its written notice to
Cumorah requesting an equity investment. The Company may not make equity
investment requests of Cumorah more often than every seven trading days.
Cumorah is permitted to sell stock during the term of the Agreement, subject to
compliance with applicable securities laws.

<P style="font-size: 10pt; text-indent: 4%" align="justify">The Company seeks
to raise capital under the Agreement. Cumorah is not obligated to invest under
the Agreement unless all of the conditions for a required investment are
satisfied, including but not limited to adequate trading volume, adequate
market capitalization, and the absence of excess volatility in the
Company&#8217;s trading price at the time of the request by the Company. To the
extent that the Company raises capital under the Agreement, significant
dilution of ownership may be experienced by existing shareholders of the
Company, its stock may experience selling pressure in the market, and its stock
price may decline.

<P style="font-size: 10pt; text-indent: 4%" align="justify">A copy of the
complete Agreement is attached to this Report on Form 8-K as Exhibit&nbsp;99.1.

<P style="font-size: 10pt" align="justify"><B>SECTION 9. FINANCIAL STATEMENTS
AND EXHIBITS</B>

<P style="font-size: 10pt" align="justify"><B>Item&nbsp;9.01 Financial
Statements and Exhibits.</B>

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">
  <TD style="background: none transparent scroll repeat 0% 0%"
width="4%">&nbsp;</TD>
  <TD nowrap align="left" width="3%">(d)</TD>
  <TD width="1%">&nbsp;</TD>
  <TD>
<DIV style="text-align: justify">Exhibits</DIV>
</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt; margin-left: 6%" align="justify">99.1 Periodic
Equity Investment Agreement, dated December&nbsp;8, 2008, by and between
Cereplast, Inc. and Cumorah Capital, Inc.

<P style="font-size: 10pt" align="center">-1-

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B>

<P style="font-size: 10pt; text-indent: 4%" align="justify">Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the registrant
has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

<P style="font-size: 10pt; margin-left: 45%" align="justify"><U><B>CEREPLAST,
INC.</B></U> <BR>
(Registrant)

<P>
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">

 <TR
style="font-size: 10pt; background: none transparent scroll repeat 0% 0%; color: #000000"
valign="top">  <TD colspan="2">
<DIV style="text-align: justify">Date: December&nbsp;12, 2008</DIV>
</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt; margin-left: 45%" align="justify"><U>/s/ <I>Frederic
Scheer, Chief Executive
Officer</I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><BR>
Frederic
Scheer, Chief Executive Officer<BR>


<P style="font-size: 10pt" align="center">-2-

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="center"><B>EXHIBIT INDEX</B>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
 <TR style="font-size: 10pt" valign="bottom">
  <TD style="border-bottom: #000000 1px solid" nowrap align="left"><B>Exhibit
Index</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid" nowrap
align="center"><B>Description&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">99.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Periodic Equity Investment Agreement, dated
December&nbsp;8, 2008, by and between Cereplast, Inc. and Cumorah Capital,
Inc.</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">-3-

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c78239e8vk.htm", "description": "FORM 8-K", "secsgml_size_bytes": 11436}]
{"company-data": {"conformed-name": "Cereplast Inc", "cik": "0001324759", "assigned-sic": "2821", "irs-number": "000000000"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-126378", "film-number": "081247134"}, "business-address": {"street1": "3433 EL SEGUNDO BOULEVARD", "city": "HAWTHORNE", "state": "CA", "zip": "90250", "phone": "310-676-5000"}, "mail-address": {"street1": "3433 EL SEGUNDO BOULEVARD", "city": "HAWTHORNE", "state": "CA", "zip": "90250"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): December 8, 2008
CEREPLAST, INC.
(Exact name of registrant as specified in its charter)
Nevada
333-126378
91-2154289
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
3411-3421 West El Segundo
Boulevard, Hawthorne, California
90250
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(310) 676-5000
Not Applicable
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SECTION 1. REGISTRANT'S
BUSINESS AND OPERATIONS
Item 1.01
Entry Into a Material Definitive
Agreement
On December 8,
2008, Cereplast, Inc., a Nevada corporation (the "Company") entered
into a Periodic Equity Investment Agreement (the "Agreement") with
Cumorah Capital, Inc., a Nevada corporation ("Cumorah"). Under the
Agreement, Cumorah has agreed to invest up to $20,000,000 of capital into the
Company during the term of the Agreement at the rate of $250,000 per
investment, subject to the ongoing satisfaction of certain conditions specified
in the Agreement. The Agreement commences on December 8, 2008 and
terminates on the earlier to occur of (i) the date the total maximum
investments of $20,000,000 is made under the Agreement,
(ii) December 8, 2010, or (iii) the date the Agreement is
automatically terminated because of the occurrence of any of the events
described in Section 2.4 of the Agreement.
In response to
requests for equity investments by the Company from time to time during the
term of the Agreement, Cumorah may fulfill its funding obligation by purchasing
the Company's common stock at a purchase price equal to 90% of the market
price, if the stock is covered by a Registration Statement filed pursuant to
Section 5 of the Securities Act of 1933, as amended, or 60% of the market
price, if the stock is restricted and not registered.
The Agreement
defines the market price as the lowest closing bid price of the Company's
common stock on the OTC Bulletin Board during the five consecutive trading days
immediately preceding the date that the Company delivers its written notice to
Cumorah requesting an equity investment. The Company may not make equity
investment requests of Cumorah more often than every seven trading days.
Cumorah is permitted to sell stock during the term of the Agreement, subject to
compliance with applicable securities laws.
The Company seeks
to raise capital under the Agreement. Cumorah is not obligated to invest under
the Agreement unless all of the conditions for a required investment are
satisfied, including but not limited to adequate trading volume, adequate
market capitalization, and the absence of excess volatility in the
Company's trading price at the time of the request by the Company. To the
extent that the Company raises capital under the Agreement, significant
dilution of ownership may be experienced by existing shareholders of the
Company, its stock may experience selling pressure in the market, and its stock
price may decline.
A copy of the
complete Agreement is attached to this Report on Form 8-K as Exhibit 99.1.
SECTION 9. FINANCIAL STATEMENTS
AND EXHIBITS
Item 9.01 Financial
Statements and Exhibits.
(d)
Exhibits
99.1 Periodic
Equity Investment Agreement, dated December 8, 2008, by and between
Cereplast, Inc. and Cumorah Capital, Inc.
-1-
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the registrant
has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
CEREPLAST,
INC.
(Registrant)
Date: December 12, 2008
/s/
Frederic
Scheer, Chief Executive
Officer
Frederic
Scheer, Chief Executive Officer
-2-
EXHIBIT INDEX
Exhibit
Index
Description
99.1
Periodic Equity Investment Agreement, dated
December 8, 2008, by and between Cereplast, Inc. and Cumorah Capital,
Inc.
-3-